Pepro Tech
A more recent version of this article appeared on April 1, 2005

Published online before print December 23, 2004
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0404262v1
77/4/513    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandoval-Montes, C.
Right arrow Articles by Santos-Argumedo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandoval-Montes, C.
Right arrow Articles by Santos-Argumedo, L.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0404262

Received for publication April 30, 2004.
Revised November 24, 2004.
Accepted for publication November 26, 2004.

Article

CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines

Claudia Sandoval-Montes and Leopoldo Santos-Argumedo @

Departamento de Biomedicina Molecular, Centro de Investigación y Estudios Avanzados, I.P.N., México


arrow
Abstract

CD38 is an ~45-kDa type II transmembrane glycoprotein expressed by hematopoietic and nonhematopoietic cells. Its surface expression is under complex control and varies during lymphocyte development, activation, and differentiation, suggesting an important role in these processes. Murine CD38 has been mainly characterized on B lymphocytes, and in humans, the molecule has been studied in T cells. This paper provides evidences that murine CD38 is regulated tightly during T cell activation and differentiation. On the periphery, a subset of mature T lymphocytes was identified by the expression of CD38. These cells showed an activated phenotype; they were larger and more granular than their negative counterparts. In accord with this observation, in vitro-activated T cells up-regulated CD38. Memory T lymphocytes also were CD38-positive. It is interesting that T cells expressing high levels of CD38 had a reduced, proliferative capacity but displayed an improved potential to produce interleukin-2 and interferon-{gamma}, suggesting a role of this molecule during T cell activation and differentiation.

Key Words: subpopulations • naïve • memory • T lymphocytes




This article has been cited by other articles:


Home page
 J. Immunol.Home page
C. A. Cox, G. Shi, H. Yin, B. P. Vistica, E. F. Wawrousek, C.-C. Chan, and I. Gery
Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities
J. Immunol., June 1, 2008; 180(11): 7414 - 7422.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. C. Rodriguez-Alba, M. E. Moreno-Garcia, C. Sandoval-Montes, V. H. Rosales-Garcia, and L. Santos-Argumedo
CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen
Blood, April 1, 2008; 111(7): 3644 - 3652.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Tinhofer, G. Rubenzer, C. Holler, E. Hofstaetter, M. Stoecher, A. Egle, M. Steurer, and R. Greil
Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia
Blood, November 1, 2006; 108(9): 2950 - 2956.
[Abstract] [Full Text] [PDF]